🌍23 centres are now opened to recruitment in France, The UK, Germany, the Czech Republic, Spain and the Netherlands.🏥 2 additional sites will follow at the beginning of 2026.👩⚕️ About 180 patients have been recruited so far in the trial, and a strong effort is being...
Regulatory approval has now been obtained for all participating coutries.✔️ Since the beginning of the RITA-MI2 trial in 2022, 20 recruitment centres, in France, the UK, Germany, Spain and the Czech Republic have opened for recruitment. 👏 4 additional centres, in...
The RITA-MI2 trial is listed on clinicaltrials.gov, under registration number NCT05211401. Study Description Brief Summary The main objective is to compare the effect of a single injection of two doses of rituximab versus placebo on 6 months left...
The RITA-MI2 trial French CRA team sent a newsflash to all French recruiting centres in July 2022. Have a look ! Newsflash 22 07 2022
🎉The RITA-MI2 clinical trial has been launched today at Bichat Hospital, Paris.🏥👩⚕️ More information to come
